The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma
Open accessAbstract
Background Adrenocortical carcinoma (ACC) is a rare disease without effective chemotherapy treated most appropriately with resection. The aim of this study was to evaluate our experience with liver resection for metastatic ACC.Methods This study is a retrospective review of patients who underwent liver resection or radiofrequency ablation (RFA) for ACC from 1979 to 2009.Results A total of 27 patients were identified. Of the 27, 19 underwent liver resection. Of the 19, 10 had a single liver lesion, and 18 of 19 were rendered free of disease in the liver, although only 11 of 19 were rendered completely free of disease because of extrahepatic disease (EHD). Of the 19, 13 had synchronous EHD. Also, 6 of 17 remained disease free in the liver at a median follow-up of 6.2 years (status of 2 of 19 was unknown). Of the 27 patients, 8 underwent RFA, 7 of 8 became free of disease in the liver, and 5 of 7 had EHD. No patients responded to prior chemotherapy. Median overall survival and survival of patients who underwent liver resection or RFA were both 1.9 years (0.2-12 + years); 5-year actuarial survivals were 29% and 29%, respectively. Disease-free interval (DFI) greater than 9 months from primary resection was associated with longer survival (median 4.1 vs 0.9 years; P = .013).Conclusions This study is a tertiary institution series of liver resection and RFA for ACC. Given the lack of effective systemic treatment options and the safety of resection and ablation, liver resection or RFA may be considered in selected patients with ACC metastatic to the liver especially with a long DFI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RFA has been successfully employed in the palliative setting, rendering patients free of liver metastasis (352).”
From Adrenocortical carcinoma (2014) · cites this paper as [352]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Faßnacht, M., Daffara, F., Tauchmanovà, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 759
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C. (2008) · Cancer · doi:10.1002/cncr.23886 · Cited by 493
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Crucitti, F., Bellantone, R., Ferrante, A., Boscherini, M., & Crucitti, P. (1996) · Surgery · doi:10.1016/s0039-6060(96)80164-4 · Cited by 247
Management of adrenocortical carcinoma
Allolio, B., Hahner, S., Weismann, D., & Fassnacht, M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01881.x · Cited by 214
Partial Hepatectomy for Metastases From Noncolorectal, Nonneuroendocrine Carcinoma
Weitz, J., Blumgart, L. H., Fong, Y., Jarnagin, W. R., D'Angelica, M. I., Harrison, L. E., & DeMatteo, R. P. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000150244.72285.ad · Cited by 194
Manetti, L., Bogazzi, F., Giovannetti, C., Raffaelli, V., Genovesi, M., Pellegrini, G., Ruocco, L. A., Iannelli, A., & Martino, E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0583 · Cited by 139
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma
Lee, J. E., Berger, D. H., El‐Naggar, A. K., Hickey, R. C., Vassilopoulou‐Sellin, R., Gagel, R. F., Burgess, M. A., & Evans, D. B. (1995) · Surgery · doi:10.1016/s0039-6060(05)80119-9 · Cited by 105
Jensen, J. C. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410280059008 · Cited by 81
Cited by
Sorted by citations
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Update in Adrenocortical Carcinoma
Faßnacht, M., Kroiß, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
Libé, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00045 · Cited by 233
Gaujoux, S., Mihai, R., Carnaille, B. M. L., Dousset, B. E., Fiori, C., Porpiglia, F., Hellman, P., Iacobone, M., Kraimps, J. L., Donatini, G., et al. (2017) · British journal of surgery · doi:10.1002/bjs.10414 · Cited by 226
Metadata
- Authors
- Ripley, R. T., Kemp, C. D., Davis, J. L., Langan, R. C., Royal, R. E., Libutti, S. K., Steinberg, S. M., Wood, B. J., Kammula, U. S., Fojo, T., & Avital, I.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Ripley, R. Taylor
- ORCID
- Venue
- Annals of Surgical Oncology
- Published
- 2011-02-08
- Volume
- 18
- Issue
- 7
- Pages
- 1972-1979
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- PMC
- PMC3272672
- OpenAlex
- W2035711343
- Cited by
- 62
- References
- 20
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 3
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (ZIABC011003, ZIABC010626, ZIDBC011242)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- adrenocortical carcinoma, liver metastasis, hepatectomy, radiofrequency ablation, extrahepatic disease, disease-free interval, overall survival, synchronous metastases
- MeSH terms
- Adolescent, Adrenal Cortex Neoplasms, Adult, Aged, Child, Combined Modality Therapy, Female, Follow-Up Studies, Hepatectomy, Humans, Liver Neoplasms, Male, Middle Aged, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Catheter Ablation, Adrenocortical Carcinoma, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
